BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 22954590)

  • 1. Loss of Mel-18 enhances breast cancer stem cell activity and tumorigenicity through activating Notch signaling mediated by the Wnt/TCF pathway.
    Won HY; Lee JY; Shin DH; Park JH; Nam JS; Kim HC; Kong G
    FASEB J; 2012 Dec; 26(12):5002-13. PubMed ID: 22954590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CBX7 inhibits breast tumorigenicity through DKK-1-mediated suppression of the Wnt/β-catenin pathway.
    Kim HY; Park JH; Won HY; Lee JY; Kong G
    FASEB J; 2015 Jan; 29(1):300-13. PubMed ID: 25351982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of ΔNp63α induces a stem cell phenotype in MCF7 breast carcinoma cell line through the Notch pathway.
    Du Z; Li J; Wang L; Bian C; Wang Q; Liao L; Dou X; Bian X; Zhao RC
    Cancer Sci; 2010 Nov; 101(11):2417-24. PubMed ID: 20950370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HES1-mediated inhibition of Notch1 signaling by a Gemini vitamin D analog leads to decreased CD44(+)/CD24(-/low) tumor-initiating subpopulation in basal-like breast cancer.
    So JY; Wahler J; Das Gupta S; Salerno DM; Maehr H; Uskokovic M; Suh N
    J Steroid Biochem Mol Biol; 2015 Apr; 148():111-21. PubMed ID: 25541438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Function of Integrin-Linked Kinase in Modulating the Stemness of IL-6-Abundant Breast Cancer Cells by Regulating γ-Secretase-Mediated Notch1 Activation in Caveolae.
    Hsu EC; Kulp SK; Huang HL; Tu HJ; Salunke SB; Sullivan NJ; Sun D; Wicha MS; Shapiro CL; Chen CS
    Neoplasia; 2015 Jun; 17(6):497-508. PubMed ID: 26152358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of Bmi1 inhibits the stemness properties and tumorigenicity of human bladder cancer stem cell-like side population cells.
    Zhu D; Wan X; Huang H; Chen X; Liang W; Zhao F; Lin T; Han J; Xie W
    Oncol Rep; 2014 Feb; 31(2):727-36. PubMed ID: 24337040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WNT pathway inhibitor pyrvinium pamoate inhibits the self-renewal and metastasis of breast cancer stem cells.
    Xu L; Zhang L; Hu C; Liang S; Fei X; Yan N; Zhang Y; Zhang F
    Int J Oncol; 2016 Mar; 48(3):1175-86. PubMed ID: 26781188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Notch and Wnt/β-catenin signaling pathway play important roles in activating liver cancer stem cells.
    Wang R; Sun Q; Wang P; Liu M; Xiong S; Luo J; Huang H; Du Q; Geller DA; Cheng B
    Oncotarget; 2016 Feb; 7(5):5754-68. PubMed ID: 26735577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Wnt/β-catenin pathway regulates self-renewal of cancer stem-like cells in human gastric cancer.
    Cai C; Zhu X
    Mol Med Rep; 2012 May; 5(5):1191-6. PubMed ID: 22367735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIF-2α promotes conversion to a stem cell phenotype and induces chemoresistance in breast cancer cells by activating Wnt and Notch pathways.
    Yan Y; Liu F; Han L; Zhao L; Chen J; Olopade OI; He M; Wei M
    J Exp Clin Cancer Res; 2018 Oct; 37(1):256. PubMed ID: 30340507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells.
    Liu S; Dontu G; Mantle ID; Patel S; Ahn NS; Jackson KW; Suri P; Wicha MS
    Cancer Res; 2006 Jun; 66(12):6063-71. PubMed ID: 16778178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-1 down-regulates proliferation and migration of breast cancer stem cells by inhibiting the Wnt/β-catenin pathway.
    Liu T; Hu K; Zhao Z; Chen G; Ou X; Zhang H; Zhang X; Wei X; Wang D; Cui M; Liu C
    Oncotarget; 2015 Dec; 6(39):41638-49. PubMed ID: 26497855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear Factor Erythroid-Derived 2-Like 2-Induced Reductive Stress Favors Self-Renewal of Breast Cancer Stem-Like Cells
    Kim DH; Jang JH; Kwon OS; Cha HJ; Youn HJ; Chun KS; Surh YJ
    Antioxid Redox Signal; 2020 Jun; 32(18):1313-1329. PubMed ID: 31672029
    [No Abstract]   [Full Text] [Related]  

  • 14. Fascin Is Critical for the Maintenance of Breast Cancer Stem Cell Pool Predominantly via the Activation of the Notch Self-Renewal Pathway.
    Barnawi R; Al-Khaldi S; Majed Sleiman G; Sarkar A; Al-Dhfyan A; Al-Mohanna F; Ghebeh H; Al-Alwan M
    Stem Cells; 2016 Dec; 34(12):2799-2813. PubMed ID: 27502039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-epigenetic function of HDAC8 in regulating breast cancer stem cells by maintaining Notch1 protein stability.
    Chao MW; Chu PC; Chuang HC; Shen FH; Chou CC; Hsu EC; Himmel LE; Huang HL; Tu HJ; Kulp SK; Teng CM; Chen CS
    Oncotarget; 2016 Jan; 7(2):1796-807. PubMed ID: 26625202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ShRNA targeting Notch1 sensitizes breast cancer stem cell to paclitaxel.
    Mao J; Song B; Shi Y; Wang B; Fan S; Yu X; Tang J; Li L
    Int J Biochem Cell Biol; 2013 Jun; 45(6):1064-73. PubMed ID: 23500524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COX-2 Induces Breast Cancer Stem Cells via EP4/PI3K/AKT/NOTCH/WNT Axis.
    Majumder M; Xin X; Liu L; Tutunea-Fatan E; Rodriguez-Torres M; Vincent K; Postovit LM; Hess D; Lala PK
    Stem Cells; 2016 Sep; 34(9):2290-305. PubMed ID: 27301070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mel-18 controls the enrichment of tumor-initiating cells in SP fraction in mouse breast cancer.
    Janakiraman H; Nobukiyo A; Inoue H; Kanno M
    Hiroshima J Med Sci; 2011 Jun; 60(2):25-35. PubMed ID: 21970185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mel-18 negatively regulates stem cell-like properties through downregulation of miR-21 in gastric cancer.
    Wang XF; Zhang XW; Hua RX; Du YQ; Huang MZ; Liu Y; Cheng YF; Guo WJ
    Oncotarget; 2016 Sep; 7(39):63352-63361. PubMed ID: 27542229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Notch signaling plays a crucial role in cancer stem-like cells maintaining stemness and mediating chemotaxis in renal cell carcinoma.
    Xiao W; Gao Z; Duan Y; Yuan W; Ke Y
    J Exp Clin Cancer Res; 2017 Mar; 36(1):41. PubMed ID: 28279221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.